These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2520624)
21. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine. Reynolds JC; Schoen RE; Maislin G; Zangari GG Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361 [TBL] [Abstract][Full Text] [Related]
22. Famotidine in the management of duodenal ulcer: experience in Italy. Barbara L; Corinaldesi R; Bianchi Porro G; Lazzaroni M; Blasi A; Mangiameli A; Carratelli L; Wilkins A; Cheli R; Bovero E Digestion; 1985; 32 Suppl 1():24-31. PubMed ID: 2866133 [TBL] [Abstract][Full Text] [Related]
23. A multicenter, double-blind, randomized, placebo-controlled comparison of nocturnal and twice-a-day famotidine in the treatment of active duodenal ulcer disease. Gitlin N; McCullough AJ; Smith JL; Mantell G; Berman R Gastroenterology; 1987 Jan; 92(1):48-53. PubMed ID: 2877912 [TBL] [Abstract][Full Text] [Related]
24. Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers. Laine L; Kivitz AJ; Bello AE; Grahn AY; Schiff MH; Taha AS Am J Gastroenterol; 2012 Mar; 107(3):379-86. PubMed ID: 22186979 [TBL] [Abstract][Full Text] [Related]
25. A single nocturnal dose of famotidine for the treatment of duodenal ulcer: evaluation of efficacy and safety. al-Freihi HM; al-Hamdan A; al-Qurain A; al-Gindan YM; Ibrahim EM; al-Ghassab G; Nabi HI Trop Gastroenterol; 1991; 12(2):77-82. PubMed ID: 1949207 [TBL] [Abstract][Full Text] [Related]
26. Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease. Delle Fave G; Annibale B; Franceschi M; Quatrini M; Cassetta MR; Torsoli A Aliment Pharmacol Ther; 1992 Aug; 6(4):469-78. PubMed ID: 1420739 [TBL] [Abstract][Full Text] [Related]
27. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease. Thomson AB Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583 [TBL] [Abstract][Full Text] [Related]
28. Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial. Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E Ital J Gastroenterol; 1991 Feb; 23(2):65-9. PubMed ID: 1747505 [TBL] [Abstract][Full Text] [Related]
30. [Duodenal ulcer, study of gastric secretion and rational treatment with famotidine in different doses]. Santoro E; Morucci P; Idotta G; Scutari F Ann Gastroenterol Hepatol (Paris); 1989 Oct; 25(5):211-4. PubMed ID: 2817767 [TBL] [Abstract][Full Text] [Related]
31. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220 [TBL] [Abstract][Full Text] [Related]
32. Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine. Hartmann H; Fölsch UR Digestion; 1988; 39(3):156-61. PubMed ID: 3061859 [TBL] [Abstract][Full Text] [Related]
33. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects. Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470 [TBL] [Abstract][Full Text] [Related]
34. Treatment of acute duodenal ulcers with famotidine and its comparison with other H2 blockers. Akhtar MA; Rashid P; Khan MA J Pak Med Assoc; 1990 Jun; 40(6):136-7. PubMed ID: 1975277 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Poynard T; Lemaire M; Agostini H Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162 [TBL] [Abstract][Full Text] [Related]
36. [Time of famotidine administration and healing of duodenal ulcer: is 18.00 o'clock of importance?]. Brunner H; Weiss W Wien Med Wochenschr; 1992; 142(18):414-7. PubMed ID: 1475987 [TBL] [Abstract][Full Text] [Related]
37. A multicenter, randomized, double-blind study comparing famotidine with cimetidine in the treatment of active duodenal ulcer disease. Rodrigo L; Viver J; Conchillo F; Barrio E; Forné M; Zozaya JM; Alvarez A; Dieguez P; Muñoz M; Panés J Digestion; 1989; 42(2):86-92. PubMed ID: 2570005 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing. Bianchi Porro G; Parente F; Sangaletti O Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980 [TBL] [Abstract][Full Text] [Related]
39. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide. Reynolds JC Clin Ther; 1988; 10(4):436-49. PubMed ID: 3079011 [TBL] [Abstract][Full Text] [Related]
40. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine. Rohner HG; Gugler R Am J Med; 1986 Oct; 81(4B):13-6. PubMed ID: 2877569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]